These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16709797)

  • 1. Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity.
    Frisancho-Kiss S; Nyland JF; Davis SE; Barrett MA; Gatewood SJ; Njoku DB; Cihakova D; Silbergeld EK; Rose NR; Fairweather D
    J Immunol; 2006 Jun; 176(11):6411-5. PubMed ID: 16709797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: cross-regulation by TLR4 and T cell Ig mucin-3 determines sex differences in inflammatory heart disease.
    Frisancho-Kiss S; Davis SE; Nyland JF; Frisancho JA; Cihakova D; Barrett MA; Rose NR; Fairweather D
    J Immunol; 2007 Jun; 178(11):6710-4. PubMed ID: 17513715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
    Im SH; Barchan D; Maiti PK; Fuchs S; Souroujon MC
    J Immunol; 2001 Jun; 166(11):6893-8. PubMed ID: 11359850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity.
    Zhao J; Lei Z; Liu Y; Li B; Zhang L; Fang H; Song C; Wang X; Zhang GM; Feng ZH; Huang B
    J Immunol; 2009 May; 182(10):6618-24. PubMed ID: 19414817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunoglobulin and mucin domain 3 acts as a negative regulator of atherosclerosis.
    Foks AC; Ran IA; Wasserman L; Frodermann V; Ter Borg MN; de Jager SC; van Santbrink PJ; Yagita H; Akiba H; Bot I; Kuiper J; van Puijvelde GH
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2558-65. PubMed ID: 23990206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells.
    Anderson AC; Anderson DE; Bregoli L; Hastings WD; Kassam N; Lei C; Chandwaskar R; Karman J; Su EW; Hirashima M; Bruce JN; Kane LP; Kuchroo VK; Hafler DA
    Science; 2007 Nov; 318(5853):1141-3. PubMed ID: 18006747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An important role of CD80/CD86-CTLA-4 signaling during photocarcinogenesis in mice.
    Loser K; Scherer A; Krummen MB; Varga G; Higuchi T; Schwarz T; Sharpe AH; Grabbe S; Bluestone JA; Beissert S
    J Immunol; 2005 May; 174(9):5298-305. PubMed ID: 15843526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
    Sánchez-Fueyo A; Tian J; Picarella D; Domenig C; Zheng XX; Sabatos CA; Manlongat N; Bender O; Kamradt T; Kuchroo VK; Gutiérrez-Ramos JC; Coyle AJ; Strom TB
    Nat Immunol; 2003 Nov; 4(11):1093-101. PubMed ID: 14556005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
    Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
    J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Established T cell-driven germinal center B cell proliferation is independent of CD28 signaling but is tightly regulated through CTLA-4.
    Walker LS; Wiggett HE; Gaspal FM; Raykundalia CR; Goodall MD; Toellner KM; Lane PJ
    J Immunol; 2003 Jan; 170(1):91-8. PubMed ID: 12496387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
    Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
    Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-12 receptor beta 1 and Toll-like receptor 4 increase IL-1 beta- and IL-18-associated myocarditis and coxsackievirus replication.
    Fairweather D; Yusung S; Frisancho S; Barrett M; Gatewood S; Steele R; Rose NR
    J Immunol; 2003 May; 170(9):4731-7. PubMed ID: 12707353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD11b+ monocytes abrogate Th17 CD4+ T cell-mediated experimental autoimmune myocarditis.
    Valaperti A; Marty RR; Kania G; Germano D; Mauermann N; Dirnhofer S; Leimenstoll B; Blyszczuk P; Dong C; Mueller C; Hunziker L; Eriksson U
    J Immunol; 2008 Feb; 180(4):2686-95. PubMed ID: 18250481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection.
    Mencacci A; Cenci E; Del Sero G; Fé d'Ostiani C; Mosci P; Trinchieri G; Adorini L; Romani L
    J Immunol; 1998 Dec; 161(11):6228-37. PubMed ID: 9834110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superantigen-induced regulatory T cells display different suppressive functions in the presence or absence of natural CD4+CD25+ regulatory T cells in vivo.
    Grundström S; Cederbom L; Sundstedt A; Scheipers P; Ivars F
    J Immunol; 2003 May; 170(10):5008-17. PubMed ID: 12734345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory networks induced by live parasites impair both Th1 and Th2 pathways in patent lymphatic filariasis: implications for parasite persistence.
    Babu S; Blauvelt CP; Kumaraswami V; Nutman TB
    J Immunol; 2006 Mar; 176(5):3248-56. PubMed ID: 16493086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical negative regulation of type 1 T cell immunity and immunopathology by signaling adaptor DAP12 during intracellular infection.
    Divangahi M; Yang T; Kugathasan K; McCormick S; Takenaka S; Gaschler G; Ashkar A; Stampfli M; Gauldie J; Bramson J; Takai T; Brown E; Yokoyama WM; Aoki N; Xing Z
    J Immunol; 2007 Sep; 179(6):4015-26. PubMed ID: 17785840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.